(Q36025114)

11 August 2017

Pharmacokinetics of desloratadine in children between 2 and 11 years of age (English)

1 reference

11 August 2017

1 reference

Samir Gupta

1

1 reference

11 August 2017

Sauzanne Khalilieh

series ordinal

2

1 reference

11 August 2017

Bhavna Kantesaria

series ordinal

3

1 reference

11 August 2017

Christopher Banfield

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

63

1 reference

11 August 2017

5

1 reference

11 August 2017

534-540

1 reference

Current concepts and therapeutic strategies for allergic rhinitis in school-age children

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

Desloratadine: an update of its efficacy in the management of allergic disorders

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitis [ISRCTN32042139]

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

Therapeutic approaches to allergic rhinitis: treating the child

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

Chronic urticaria in childhood

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study

2 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02810.X

Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02810.X

Safety of desloratadine syrup in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02810.X

Validation of a sensitive and automated 96-well solid-phase extraction liquid chromatography-tandem mass spectrometry method for the determination of desloratadine and 3-hydroxydesloratadine in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02810.X

Evidence of desloratadine syrup efficacy and tolerability in children with pollen-induced allergic rhinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2006.02810.X

Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000753

10.1111/J.1365-2125.2006.02810.X

23 September 2018

Identifiers

DOI

1 reference

release_oqd4mtvozrfhranfrlsvqgj6pq

11 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oqd4mtvozrfhranfrlsvqgj6pq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

11 August 2017

PubMed publication ID

17488362

1 reference